Impact of antiphospholipid antibodies on heart valve involvements in systemic lupus erythematosus: based on CSTAR cohort

Impact of antiphospholipid antibodies on heart valve involvements in systemic lupus erythematosus: based on CSTAR cohort

Objective This study aims to evaluate the role of antiphospholipid antibodies (aPLs) in patients with SLE with heart valve diseases (HVDs).Methods This prospective study included consecutive patients with SLE who visited Peking Union Medical College Hospital between April 1999 and December 2024. Ech...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wei Bai, Shangzhu Zhang, Xiaofeng Zeng, Hui Jiang, Jiuliang Zhao, Mengtao Li, Yan Zhao, Junyan Qian, Ziqian Wang, Can Huang, Yuan Zhao, Xiaoxiao Guo, Liying Peng, Siyun Chen, Yangzhong Zhou, Chuhan Wang
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-06-01
Series:	Lupus Science and Medicine
Online Access:	https://lupus.bmj.com/content/12/1/e001674.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): the effect of different antiphospholipid antibodies isotypes
by: Can Huang, et al.
Published: (2025-01-01)

Systemic lupus erythematosus related thrombotic microangiopathy: A retrospective study based on Chinese SLE Treatment and Research Group (CSTAR) registry
by: Yupei Zhang, et al.
Published: (2025-03-01)

IgG glycosylation profiling of systemic lupus erythematosus using lectin microarray
by: Shangzhu Zhang, et al.
Published: (2025-04-01)

Systematic Review of the Outcomes and Prognostic Factors of Patients With Systemic Lupus Erythematosus-Associated Thrombotic Microangiopathy
by: Yixuan Gai, et al.
Published: (2025-07-01)

Clinical Features and Outcomes of Neuropsychiatric Systemic Lupus Erythematosus in China
by: Shangzhu Zhang, et al.
Published: (2021-01-01)

Antiphospholipide antibodies subtypes in systemic lupus erythematosus and antiphospholipid syndrome
by: T M Reshetnyak, et al.
Published: (2005-10-01)

Clinical Characteristics of Systemic Lupus Erythematosus with Cirrhosis
by: Hanxiao You, et al.
Published: (2020-01-01)

Deciphering the transcriptomic landscape of systemic lupus erythematosus-associated pulmonary arterial hypertension
by: Yutong Li, et al.
Published: (2025-03-01)

Chronic abdominal aortic occlusive disease related to antiphospholipid syndrome: a rare presentation
by: Wei Liu, et al.
Published: (2024-02-01)

Extra criterial antiphospholipid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data)
by: F. A. Cheldieva, et al.
Published: (2021-10-01)

Predictive Factors for the Common Adverse Maternal and Fetal Outcomes in Pregnancies Complicated by Systemic Lupus Erythematosus
by: Qianwen Dai, et al.
Published: (2024-04-01)

Remnant cholesterol predicts risk of recurrent thrombosis beyond LDL-cholesterol in patients with antiphospholipid syndrome
by: Bin Cai, et al.
Published: (2025-04-01)

Netosis in the pathogenesis of antiphospholipid syndrome and systemic lupus erythematosus
by: K. S. Nurbaeva, et al.
Published: (2021-10-01)

A family case of systemic lupus erythematosus with antiphospholipide syndrome
by: O L Alexandrova, et al.
Published: (2005-08-01)

Aminoquinoline drugs in the treatment of systemic lupus erythematosus and antiphospholipid syndrome
by: L V Kondratyeva, et al.
Published: (2008-08-01)

Von Willebrand factor antigen in systemic lupus erythematosus and antiphospholipid syndrome
by: A A Novikov, et al.
Published: (2004-08-01)

Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-11-01)

Atherosclerotic vessel damage in systemic lupus erythematosus and antiphospholipid syndrome in men
by: A. I. Iljina, et al.
Published: (2005-10-01)

Corticobasal Syndrome Associated with Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus
by: Ritsuo Hashimoto, et al.
Published: (2018-01-01)

Antibodies to domain I β2 -glycoprotein 1 in patients with antiphospholipid syndrome and systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-07-01)

CLINICAL SIGNIFICANCE OF ANTIPHOSPHOLIPID ANTIBODIES AND GENE MUTATIONS IN HEMOSTASIS OF CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND JUVENILE DERMATOMYOSITIS
by: O.A. Solntseva
Published: (2006-04-01)

Non-criteria antiphospholipid antibody profiles and thrombotic outcomes in a cohort of patients with systemic lupus erythematosus
by: Ann Elaine Clarke, et al.
Published: (2024-12-01)

Hyperhomocysteinemia - an additional risk factor of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome
by: I. E. Shirokova, et al.
Published: (2003-08-01)

A case of primary antiphospholipid syndrome under the mask of systemic lupus erythematosus
by: N. S. Pozhilenko, et al.
Published: (2022-03-01)

ISCHEMIC STROKE IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND SECONDARY ANTIPHOSPHOLIPID SYNDROME
by: P. S. Nikitenko, et al.
Published: (2019-07-01)

Clinical and endoscopic assessment of gastric state in systemic lupus erythematosus and antiphospholipid syndrome
by: I. A. Doroshkevich, et al.
Published: (2004-06-01)

Splenic infarcts in a lady with systemic lupus erythematosus and negative antiphospholipid antibodies—A rare case report
by: Amr Ashour, et al.
Published: (2023-03-01)

Case Report: Bilateral adrenal hemorrhage in a patient with systemic lupus erythematosus and antiphospholipid syndrome
by: Yuwei Wang, et al.
Published: (2025-08-01)

ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS: WHAT DISEASE IS A CAUSE OF ORGAN DAMAGES?
by: F. A. Cheldieva, et al.
Published: (2020-04-01)

Citrullinated histone H3 in systemic lupus erythematosus and antiphospholipid syndrome (preliminary results)
by: K. S. Nurbaeva, et al.
Published: (2023-08-01)

Systemic Lupus Erythematosus and Antiphospholipid Syndrome Accompanied by Mixed-Type Autoimmune Hemolytic Anemia
by: Eiji Suzuki, et al.
Published: (2023-01-01)

Pulmonary artery trunk thrombosis as a manifestation of antiphospholipid syndrome in systemic lupus erythematosus
by: T L Zlobina, et al.
Published: (2004-06-01)

Multiple sclerosis and rheumatic diseases: Rheumatoid arthritis, antiphospholipid syndrome, and systemic lupus erythematosus
by: M.A. Hernández, et al.
Published: (2025-07-01)

Chinese SLE Treatment and Research Group Registry: III. Association of Autoantibodies with Clinical Manifestations in Chinese Patients with Systemic Lupus Erythematosus
by: Jing Li, et al.
Published: (2014-01-01)

Comparative evaluation of three anti-dsDNA antibody detection methods in systemic lupus erythematosus: insights from a large monocentric cohort
by: Ruijing Lu, et al.
Published: (2025-04-01)

Coronary atherosclerosis and cerebrovascular damage in a patient with systemi9c lupus erythematosus with antiphospholipid syndrome
by: N V Seredavkina, et al.
Published: (2008-06-01)

Adrenal Hemorrhage in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome: A Case Report and Literature Review
by: Weiwei Jiang, et al.
Published: (2023-01-01)

Correction: Comparative evaluation of three anti-dsDNA antibody detection methods in systemic lupus erythematosus: insights from a large monocentric cohort
by: Ruijing Lu, et al.
Published: (2025-07-01)

Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics
by: Xiaofeng Dai, et al.
Published: (2025-03-01)

Difficulties in management of patients with systemic lupus erythematosus and antiphospholipid syndrome in combination with melanoma and infiltrative tuberculosis (clinical observations)
by: A. A. Shumilova, et al.
Published: (2021-08-01)